L
Laurence Collette
Researcher at European Organisation for Research and Treatment of Cancer
Publications - 281
Citations - 37642
Laurence Collette is an academic researcher from European Organisation for Research and Treatment of Cancer. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 78, co-authored 276 publications receiving 33811 citations. Previous affiliations of Laurence Collette include VU University Amsterdam & Université catholique de Louvain.
Papers
More filters
Journal ArticleDOI
382: Which Subgroups of Patients are at risk to die from Prostate Cancer and Benefit from Immediate Androgen Deprivation if they are not Suitable for local Treatment with Curative intent of Newly Diagnosed Prostate Cancer T0-4 N0-2 MO (EORTC 30891)?
Urs E. Studer,Laurence Collette,Peter Whelan,Walter Albrecht,Jacques Casselman,Theo M. de Reijke,Hartmut Knoenagel,Wolfgang Loidl,Santiago Isoma,Subramanian K. Sundaram,Muriel Debois +10 more
Journal ArticleDOI
Intergroup study EORTC-1532-gucg: A phase 2 randomized open-label study of oral darolutamide (ODM-201) vs. androgen deprivation therapy (ADT) with LHRH agonists or antagonist in men with hormone naive prostate cancer (PCa).
Bertrand F. Tombal,Silke Gillessen,Yohann Loriot,Sandrine Marreaud,Laurence Collette,Fred Saad +5 more
TL;DR: The aim of this trial is to investigate the activity, safety and tolerability of darolutamide as single agent, as an alternative to LHRH analogues in men requiring ADT.
Journal ArticleDOI
Oral Scientific SessionsComparison of Local Control of Brain Metastasis with Stereotactic Radiosurgery Versus Surgical Resection: A Secondary Analysis of EORTC 22952-26001
Thomas M. Churilla,I. Chowdhury,Elizabeth Handorf,Laurence Collette,Sandra Collette,Yanqun Dong,Brian M. Alexander,Martin Kocher,Riccardo Soffietti,Elizabeth B. Claus,Stephanie E. Weiss +10 more
Journal ArticleDOI
Responding to the challenges of international collaborations between the east and the west - report of the first JCOG-EORTC symposium and a perspective from young JCOG and EORTC investigators.
Kozo Kataoka,Orit Kaider-Person,Bernd Kasper,Patrick Starlinger,Carmela Caballero,Jessica Menis,Lizza E.L. Hendriks,Mitsumi Terada,Laurence Collette,Kenichi Nakamura,Denis Lacombe,Haruhiko Fukuda +11 more
TL;DR: It is aimed to describe the differences and similarities between the two groups and to identify key factors for collaboration from the perspective of the young investigators of the networks.
Book ChapterDOI
Quality of Life in Patients with Good Prognosis Metastatic Germ Cell Tumours: Comparison of Four Chemotherapy Schedules (EORTC 30941/MRC TE20)
TL;DR: To compare Quality of Life in patients with metastatic testicular cancer receiving 3 or 4 cycles of cisplatin-based chemotherapy (BEP) given over 3 or 5 days, quality of life is compared.